Published On: Wed, Oct 19th, 2016

Analyst Coverage: Laboratory Corporation Of America Holdings (NYSE:LH)


Recently stock market analysts have updated their consensus ratings on shares of Laboratory Corporation of America Holdings (NYSE:LH).

Most recent broker ratings

09/15/2016 – Laboratory Corporation of America Holdings had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 145 price target on the stock.

09/09/2016 – Citigroup began new coverage on Laboratory Corporation of America Holdings giving the company a “neutral” rating. They now have a USD 156 price target on the stock.

08/29/2016 – Laboratory Corporation of America Holdings had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 155 price target on the stock.

07/27/2016 – Laboratory Corporation of America Holdings had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 155 price target on the stock.

06/09/2016 – Laboratory Corporation of America Holdings had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 143 price target on the stock.

04/26/2016 – Laboratory Corporation of America Holdings had its “hold” rating reiterated by analysts at Jefferies. They now have a USD 131 price target on the stock.

04/26/2016 – Laboratory Corporation of America Holdings had its “neutral” rating reiterated by analysts at UBS. They now have a USD 125 price target on the stock.

04/26/2016 – Laboratory Corporation of America Holdings had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 140 price target on the stock.

02/19/2016 – Laboratory Corporation of America Holdings had its “sector perform” rating reiterated by analysts at RBC Capital. They now have a USD 130 price target on the stock.

12/22/2015 – Laboratory Corporation of America Holdings had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 125 price target on the stock.

12/17/2015 – Laboratory Corporation of America Holdings was downgraded to “hold” by analysts at Stifel Nicolaus.

10/26/2015 – Laboratory Corporation of America Holdings had its “outperform” rating reiterated by analysts at William Blair.

06/15/2015 – KeyBanc began new coverage on Laboratory Corporation of America Holdings giving the company a “overweight” rating. They now have a USD 143 price target on the stock.

05/24/2015 – Laboratory Corporation of America Holdings was upgraded to “buy” by analysts at Zacks. They now have a USD 135 price target on the stock.

04/28/2015 – Laboratory Corporation of America Holdings had its “overweight” rating reiterated by analysts at JP Morgan. They now have a USD 144 price target on the stock.

Laboratory Corporation of America Holdings has a 50 day moving average of 136.74 and a 200 day moving average of 131.71. The stock’s market capitalization is 14.15B, it has a 52-week low of 97.79 and a 52-week high of 141.32.

The share price of the company (NYSE:LH) was up +1.72%, with a high of 138.95during the day and the volume of Laboratory Corporation of America Holdings shares traded was 681650.

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.